Read the original article: How pharma can harness the cloud to transform and accelerate therapeutic development
There’s no denying it—the world has changed over the last 18 months. For pharmaceutical companies, acceleration is the new normal. Companies are challenged to push discovery and development timelines to the limit while still adhering to GxP and other regulations and while retaining tight control on intellectual property. Pharma companies are accelerating the lifecycle […]
Read the original article: How pharma can harness the cloud to transform and accelerate therapeutic development